A1CF and metabolic dysfunction-associated steatohepatitis: We also measured a reduction in KHK-C levels, consistent with our recent findings that A1CF regulates KHK-C expression through alternative splicing and showing that the decreased A1CF levels in both mice and humans with NASH are functionally relevant (Figure 2, A–E).